Necesitamos menos investigación!
DOI:
https://doi.org/10.35509/01239015.700Palabras clave:
protocolos de ensayos clínicos, modelos predictivosResumen
Con casi medio millón de citaciones encontradas en Google Académico como coautor de investigaciones en el campo y en estándares de estadística y ublicación biomédica, desde su posición como profesor de la Universidad de Oxford, director del Centro de Estadística en Medicina y de la investigación en Cáncer del Reino Unido, de la Colaboración Cochrane y de la red EQUATOR2 , Altman transformó la manera tradicional en que se presentaban los resultados de las investigaciones, promocionando y divulgando los staments para el sometimiento de manuscritos ante las revistas. Esto significa, se 2 infiere, que debe existir una especie de método de publicación para cada tipo de investigación que tiene que ver con la pregunta y los métodos empleados.
Referencias bibliográficas
Altman DG. The scandal of poor medical research. BMJ. 1994;308(6924):283-4. https://doi.org/10.1136/bmj.308.6924.2832. The EQUATOR Network website and database. Accesible en: https://www.equator-network.org/3.
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;152(11):726-32. The EQUATOR Network website and database. Accesible en: http://www.equator-network.org/reporting-guidelines/consort/https://doi.org/10.7326/0003-4819-152-11-201006010-002324.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, et al. SPIRIT 2013 Statement: Defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200-7. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/https://doi.org/10.7326/0003-4819-158-3-201302050-005835.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573-7. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/strobe/https://doi.org/10.7326/0003-4819-147-8-200710160-000106.
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development. BMJ Case Rep. 2013. 2013:bcr2013201554. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/care/
Brouwers MC, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 2016;352:i1152. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/theagree-reporting-checklist-a-tool-to-improve-reporting-ofclinical-practice-guidelines/https://doi.org/10.1136/bmj.i1152
O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245-51. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/srqr/ https://doi.org/10.1097/ACM.0000000000000388
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Vet Clin Pathol. 2012;41(1):27-31. The EQUATOR Network website and database. Accesible en http://www.equator-network.org/reporting-guidelines/improvingbioscience-research-reporting-the-arrive-guidelines-forreporting-animal-research/ https://doi.org/10.1111/j.1939-165X.2012.00418.x
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387-91. The EQUATOR Network website and database. Accesible en https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumour-marker-prognosticstudies-remark/ https://doi.org/10.1038/sj.bjc.6602678
Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol. 2011;119(2):92-101. The EQUATOR Network website and database. Accesibleen https://www.equator-network.org/reporting-guidelines/brisq/https://doi.org/10.1002/cncy.20147
Mistry P, Dunn JA, Marshall A. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines. BMC Med Res Methodol. 2017;17(1):108. The EQUATOR Network website and database. Accesible en https://www.equator-network.org/reporting-guidelines/aliterature-review-of-applied-adaptive-design-methodologywithin-the-field-of-oncology-in-randomised-controlledtrials-and-a-proposed-extension-to-the-consort-guidelines/https://doi.org/10.1186/s12874-017-0393-6
Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, et al. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol. 2015;28(9):1185-201. The EQUATOR Network website and database. Accesible en https://www.equator-network.org/reporting-guidelines/standardization-of-pathologic-evaluation-and-reportingof-postneoadjuvant-specimens-in-clinical-trials-of-breastcancer-recommendations-from-an-international-workinggroup/ https://doi.org/10.1038/modpathol.2015.74
Arroz M, Came N, Lin P, Chen W, Yuan C, Lagoo A, et al. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry B Clin Cytom. 2016;90(1):31-9. The EQUATOR Network website and database. Accesible en https://www.equator-network.org/reporting-guidelines/consensus-guidelines-on-plasma-cellmyeloma-minimal-residual-disease-analysis-and-reporting/https://doi.org/10.1002/cyto.b.21228
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing Waste From Incomplete or Unusable Reports of Biomedical Research. Lancet. 2014;383(9913):267-76. https://doi.org/10.1016/S0140-6736(13)62228-X
Bahos Z. Remembering Doug Altman. Blog BMJ Open Science. Jul 9, 2018. Accesible en: https://blogs.bmj.com/openscience/2018/07/09/remembering-doug-altman/
Sánchez-Pedraza R, Valdelamar-Jiménez A. Validación para utilización en Colombia de la escala EORTC QLQ C-30 para evaluación de la calidad de vida de los pacientes con cáncer. Rev Colomb Cancerol. 2020; 24(2):61-71
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-76. https://doi.org/10.1093/jnci/85.5.365
Valderas JM, Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res. 2008;17(9):1125-35. https://doi.org/10.1007/s11136-008-9396-4
Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2:42. https://doi.org/10.1186/s41687-018-0061-6
Suárez-Mattos A, Aristizábal I, Infante AM, Narváez C, Barajas L, Piña M, et al. Mejoría en la supervivencia de los niños con leucemia mieloide aguda en el Instituto Nacional de Cancerología de Colombia. Rev Colomb Cancerol. 2020; 24(2):72-9
Jackson SE, Chester JD. Personalised Cancer Medicine. Int J Cancer. 2015;137(2):262-6. https://doi.org/10.1002/ijc.28940
Valencia-Cuéllar A, Marulanda-Sánchez J, Calvache-EspañaJ, Andrade-Pantoja L, Arango L. Características de pacientes adultos con cáncer y su atención en el Hospital Universitario San José de Popayán, Colombia. Rev Colomb Cancerol. 2020; 24(2):80-7
Cómo citar
Descargas
Publicado
Número
Sección
Licencia
Todos los derechos reservados.
